Abstract:Purpose A 50-year-old female with excessive menstruation and severe epistaxis since childhood was studied by using phenotype and genetic diagnosis. She was diagnosed as Glanzmann thrombasthenia (GT), meanwhile, her family members with severe epistaxis were also studied. Mutation sites were detected in them. Bioinformatics software was used to explore the molecular pathogenesis which provide evidence for in vitro and in vivo experiments. Methods Platelet count and morphology, coagulation function and platelet aggregation were detected for phenotype diagnosis. Platelet membrane glycoproteins (GP) αIIb and β3 were measured by flow cytometry (FCM). Exons and their end 15bp introns of 89 genes associated with hemorrhage and thrombosis from proband were amplified by PCR and analyzed by direct DNA sequencing. Mutation site was measured by sanger sequencing in other family members. ClustalX-2.1-win software was used to analyze homology of nucleotide. PROVEAN and SIFT was used to analyze the risk of mutation site. Results The proband, along with her brother and nephew, had normal platelet account and morphology. Coagulation function showed normal while platelet aggregation in response to ADP and AA were reduced. However, they had normal platelet aggregation in response to ristocetin. FCM demonstrated that expression level of CD41 and CD61 were significantly reduced. ITGA2B c.1067T>C heterozygous missense mutation, which led to a Val356→Ala substitution in αIIb protein, existed in the three people. This mutation site was highly conserved among human, mouse, rat and zebrafish. PROVEAN prediction scored -3.48 and SIFT prediction scored 0.001. These results demonstrated ITGA2B p.Val356Ala was pathogenic. Conclusion Glanzmann thrombasthenia is a rare autosomal recessive bleeding disorder results from quantitative or qualitative defect of αIIbβ3 integrin which encoded by ITGA2B and ITGB3. The nature of GT mutations is highly variable and most cases are sporadic. In our study, ITGA2B c.1067T>C (Val356Ala) heterozygous missense mutation caused Glanzmann thrombasthenia and aroused obvious symptoms. And in general, homozygous mutation in ITGA2B were recognized to led to Glanzmann thrombasthenia while ITGA2B heterozygous mutation carriers showed mild symptoms. However, there are also some patients with gain-of-function in ITGA2B showed abnormal platelet function or amount. More experiments should be conducted to identify the function of this heterozygous mutation. Disclosures No relevant conflicts of interest to declare.

Molecular mechanisms of Glanzmann thrombasthenia caused by αⅡb P126H mutation:an in vitro experiment

Molecular mechanisms of Glanzmann thrombasthenia caused by α II b P126H mutation: An in vitro experiment

[Molecular Mechanisms of Glanzmann Thrombasthenia Caused by Alphaii B P126H Mutation: an in Vitro Experiment].

[Molecular Mechanisms of Glanzmann Thrombasthenia Caused by Alpha II B L721R and Q860X Compound Heterozygous Mutation].

A Novel Pro126his Beta Propeller Mutation in Integrin Alpha Iib Causes Glanzmann Thrombasthenia by Impairing Progression of Pro-Alpha Iib Beta 3 from Endoplasmic Reticulum to Golgi

Glanzmann Thrombasthenia Caused by a Novel Pro126His Mutation in the Integrin Α_(iib)

Mutational Analysis of 3 Glanzmann's Thrombasthenia Pedigrees

Novel Homozygous Silent Mutation of ITGB3 Gene Caused Glanzmann Thrombasthenia

Analysis of Phenotype and Genotype in Three Chinese Pedigrees with Glanzmann Thrombasthenia

Molecular analysis of phenotypes and genotypes in three Chinese pedigrees with Glanzmann thrombasthenia

A Rare Glanzmann Thrombasthenia Pedigree of C.1067T>C Heterozygous Mutation in ITGA2B Gene

New Compound Heterozygous Mutations of GPIIb in Patient with Glanzmann Thrombasthenia.

An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6

Identification of a nonsense mutation at amino acid 584-arginine of platelet glycoprotein IIb in patients with type I Glanzmann thrombasthenia.

[Molecular Analysis of Gene Mutations in Eight Patients with Glanzmann's Thrombasthenia].

[Analysis of Clinical Features and Genotype in Three Chinese Pedigrees with Glanzmann Thrombasthenia].

SINE-VNTR-Alu Retrotransposon Insertion As a Novel Mutational Event Underlying Glanzmann Thrombasthenia.

Pathogenesis and prenatal diagnosis of hereditary Glanzmann thrombasthenia

Analysis of Phenotype and Genotype in Eight Chinese Pedigrees with Glanzmann Thrombastheuia

Study on the Clinical Phenotype and Mechanism in Five Chinese Pedigrees with Glanzmann Thrombasthenia

[Mutation Screening and Prenatal Diagnosis of a Pedigree with Glanzmann's Thrombasthenia].